What is Zolpidem (Ambien) used for?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Zolpidem (Ambien) Use in Insomnia Management

Zolpidem is primarily indicated for the short-term treatment of insomnia characterized by difficulties with sleep onset and/or sleep maintenance, with the strongest evidence supporting its use for sleep onset insomnia. 1, 2

Formulations and Specific Indications

  • Immediate-release tablets (Ambien):

    • Primarily for sleep onset difficulties
    • Reduces sleep latency by 11-19 minutes compared to placebo 1
    • Available in 5mg and 10mg doses
  • Extended-release formulation (Ambien CR):

    • For both sleep onset and maintenance insomnia
    • Improves sleep maintenance in the first 6 hours of sleep 1
    • 85% of patients report being "much or very much improved" versus 48% with placebo 1
  • Sublingual formulations (Edluar, Intermezzo):

    • For middle-of-the-night awakenings with difficulty returning to sleep
    • Reduces sleep onset latency after awakening by approximately 18 minutes 1, 3

Efficacy Data

Zolpidem demonstrates efficacy in multiple sleep parameters:

  • Sleep latency: Reduces time to fall asleep by 11-19 minutes 1
  • Total sleep time: Increases by approximately 28-30 minutes 1
  • Sleep quality: Shows moderate to large improvements 1
  • Sleep efficiency: Demonstrates clinically significant improvement 1
  • Wake after sleep onset (WASO): Shows clinically significant reduction in objective measures 1

Dosing Recommendations

  • Adult women: 5mg immediate-release or 6.25mg extended-release 3, 2
  • Adult men: 10mg immediate-release or 12.5mg extended-release 3, 2
  • Elderly patients (>65 years): 5mg immediate-release or 6.25mg extended-release 1, 3, 2
  • Patients with hepatic impairment: 5mg immediate-release 2, 4

Administration Guidelines

  • Take immediately before bedtime 3, 2
  • Only take when able to get 7-8 full hours of sleep 3, 2
  • Take on an empty stomach for faster sleep onset (food can decrease absorption by 15% and delay peak concentration by 60%) 2
  • Do not take with or immediately after alcohol or other CNS depressants 3, 2

Safety Considerations and Adverse Effects

Common Adverse Effects

  • Dizziness, headache, drowsiness, nausea 1, 3, 2
  • Taste perversion (altered or unpleasant taste) 1

Serious Adverse Effects

  1. Complex sleep behaviors: Sleep-driving, sleep-eating, sleep-walking, having phone conversations or sex while not fully awake 3, 2

    • Stop medication immediately if these occur
  2. Next-day impairment:

    • Cognitive and psychomotor impairment affecting driving and activities requiring alertness 3, 2
    • Higher risk in women due to 45% slower drug clearance 3
    • Higher risk when taken with less than 7-8 hours of sleep opportunity 3
  3. Increased risk in elderly:

    • 5-fold increased risk of falls, confusion, and memory loss 3
    • 64% higher drug exposure compared to younger adults 2
  4. Other risks:

    • Associated with fractures (adjusted odds ratio 1.72) 1
    • Risk for major head injury requiring hospitalization (adjusted hazard ratio 1.67) 1

Special Populations

Elderly Patients

  • Higher sensitivity to effects due to slower elimination (32% longer half-life) 2
  • 50% higher maximum concentration and 64% higher AUC compared to younger adults 2
  • Use lowest effective dose (5mg) to minimize adverse effects 3, 2

Women

  • Clear zolpidem 45% slower than men, resulting in 45% higher blood levels 3
  • Require lower doses to minimize next-day impairment 3, 2

Contraindications

  • Previous complex sleep behaviors after taking zolpidem 2
  • Concurrent use with alcohol 3, 2
  • Inability to get 7-8 hours of sleep 3, 2

Clinical Pitfalls to Avoid

  1. Prescribing standard doses to women and elderly: Use lower doses (5mg immediate-release, 6.25mg extended-release) due to slower drug clearance 3, 2

  2. Not warning about complex sleep behaviors: These can lead to serious injury or death and require immediate discontinuation of the medication 3, 2

  3. Taking with food: Reduces absorption by 15% and delays onset by 60% 2

  4. Long-term use: Zolpidem is indicated for short-term treatment (≤4 weeks) 4, although some studies show maintained efficacy for up to 6 months without significant tolerance 4

  5. Abrupt discontinuation: May lead to rebound insomnia, though this is generally minimal when used at recommended doses 4, 5

Zolpidem remains an effective option for short-term management of insomnia when used appropriately, with careful attention to proper dosing, administration timing, and monitoring for adverse effects.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Zolpidem Safety and Efficacy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

The safety and tolerability of zolpidem--an update.

Journal of psychopharmacology (Oxford, England), 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.